Trichomonas vaginalis flavin reductase 1 and its role in metronidazole resistance

Molecular Microbiology

Volumn 91, Issue 1, 2014, Pages 198-208

  Leitsch, David ^a   Janssen, Brian D ^b   Kolarich, Daniel ^c   Johnson, Patricia J ^b   Duchêne, Michael ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MAX PLANCK INSTITUTE OF COLLOIDS AND INTERFACES   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLAVIN REDUCTASE 1; FLAVOPROTEIN; METRONIDAZOLE; PYRUVATE SYNTHASE; UNCLASSIFIED DRUG; ANTIPROTOZOAL AGENT; FLAVINE MONONUCLEOTIDE REDUCTASE; HYDROGEN PEROXIDE; ISOPROTEIN; RIBOFLAVIN DERIVATIVE;

ANTIPROTOZOAL RESISTANCE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG RESISTANCE; DRUG SENSITIVITY; ENZYME ACTIVITY; ENZYME ANALYSIS; GEL ELECTROPHORESIS; GENE SEQUENCE; MICROBIAL GENOME; NONHUMAN; PLASMID; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; STREPTOMYCES; STREPTOMYCES ACIDISCABIES; STRUCTURAL HOMOLOGY; TANDEM MASS SPECTROMETRY; TRICHOMONAS VAGINALIS; ENZYMOLOGY; GENE; GENETICS; ISOLATION AND PURIFICATION; METABOLISM;

TRICHOMONAS VAGINALIS;

ANTIPROTOZOAL AGENTS; DRUG RESISTANCE; FLAVINS; FMN REDUCTASE; GENES, PROTOZOAN; HYDROGEN PEROXIDE; METRONIDAZOLE; PROTEIN ISOFORMS; TRICHOMONAS VAGINALIS;

EID: 84891159267     PISSN: 0950382X     EISSN: 13652958     Source Type: Journal    
DOI: 10.1111/mmi.12455     Document Type: Article

References (33)

1. Carlton, J.M., Hirt, R.P., Silva, J.C., Delcher, A.L., Schatz, M., Zhao, Q., etal. (2007) Draft genome sequence of the sexually transmitted pathogen Trichomonas vaginalis. Science 315: 207-212.
2. Chapman, A., Linstead, D.J., and Lloyd, D. (1999) Hydrogen peroxide is a product of oxygen consumption by Trichomonas vaginalis. J Biosci 24: 339-344.
3. Coombs, G.H., Westrop, G.D., Suchan, P., Puzova, G., Hirt, R.P., Embley, T.M., etal. (2004) The amitochondriate eukaryote Trichomonas vaginalis contains a divergent thioredoxin-linked peroxiredoxin antioxidant system. J Biol Chem 279: 5249-5256.
4. Cui, J., Smith, T.F., and Samuelson, J. (2007) Gene expansion in Trichomonas vaginalis: a case study on transmembrane cyclases. Genome Inform 18: 35-43.
5. Davis, S.R., and Lushbaugh, W.B. (1993) Oxidative stress and Trichomonas vaginalis: the effect of hydrogen peroxide in vitro. Am J Trop Med Hyg 48: 480-487.
6. Delgadillo, M.G., Liston, D.R., Niazi, K., and Johnson, P.J. (1997) Transient and selectable transformation of the parasitic protist Trichomonas vaginalis. Proc Natl Acad Sci USA 94: 4716-4720.
7. Dyall, S.D., Koehler, C.M., Delgadillo-Correa, M.G., Bradley, P.J., Plümper, E., Leuenberger, D., etal. (2000) Presence of a member of the mitochondrial carrier family in hydrogenosomes: conservation of membrane-targeting pathways between hydrogenosomes and mitochondria. Mol Cell Biol 20: 2488-2497.
8. Ellis, J.E., Cole, D., and Lloyd, D. (1992) Influence of oxygen on the fermentative metabolism of metronidazole-sensitive and resistant strains of Trichomonas vaginalis. Mol Biochem Parasitol 56: 79-88.
9. Ellis, J.E., Wingfield, J.M., Cole, D., Boreham, P.F., and Lloyd, D. (1993) Oxygen affinities of metronidazole-resistant and -sensitive stocks of Giardia intestinalis. Int J Parasitol 23: 35-39.
10. Goldman, L.M., Upcroft, J.A., Workowski, K., and Rapkin, A. (2009) Treatment of metronidazole-resistant Trichomonas vaginalis. Sex Health 6: 345-347.
11. Kolarich, D., Jensen, P.H., Altmann, F., and Packer, N.H. (2012) Determination of site-specific glycan heterogeneity on glycoproteins. Nat Protoc 7: 1285-1298.
12. Kulda, J. (1999) Trichomonads, hydrogenosomes and drug resistance. Int J Parasitol 29: 199-212.
13. Kulda, J., Tachezy, J., and Cerkasovová, A. (1993) In vitro induced anaerobic resistance to metronidazole in Trichomonas vaginalis. J Eukaryot Microbiol 40: 262-269.
14. Leitsch, D., Kolarich, D., Binder, M., Stadlmann, J., Altmann, F., and Duchêne, M. (2009) Trichomonas vaginalis: metronidazole and other nitroimidazole drugs are reduced by the flavin enzyme thioredoxin reductase and disrupt the cellular redox system. Implications for nitroimidazole toxicity and resistance. Mol Microbiol 72: 518-536.
15. Leitsch, D., Burgess, A.G., Dunn, L.A., Krauer, K.G., Tan, K., Duchêne, M., etal. (2011) Pyruvate:ferredoxin oxidoreductase and thioredoxin reductase are involved in 5-nitroimidazole activation while flavin metabolism is linked to 5-nitroimidazole resistance in Giardia lamblia. J Antimicrob Chemother 66: 1756-1766.
16. Leitsch, D., Drinić, M., and Duchêne, M. (2012) Down-regulation of flavin reductase and alcohol dehydrogenase-1 (ADH-1) in metronidazole-resistant isolates of Trichomonas vaginalis. Mol Biochem Parasitol 183: 177-183.
17. Linstead, D.J., and Bradley, S. (1988) The purification and properties of two soluble reduced nicotinamide:acceptor oxidoreductases from Trichomonas vaginalis. Mol Biochem Parasitol 27: 125-133.
18. 2 inhibition of nitroreductase. Biochem Biophys Res Commun 67: 1267-1274.
19. Meingassner, J.G., and Thurner, J. (1979) Strain of Trichomonas vaginalis resistant to metronidazole and other 5-nitroimidazoles. Antimicrob Agents Chemother 15: 254-257.
20. Moreno, S.N.J., and Docampo, R. (1985) Mechanism of toxicity of nitro compounds used in chemotherapy of trichomoniasis. Environ Health Perspect 64: 199-208.
21. Müller, M., and Gorrell, T.E. (1983) Metabolism and metronidazole uptake in Trichomonas vaginalis isolates with different metronidazole susceptibilities. Antimicrob Agents Chemother 24: 667-673.
22. Petrin, D., Delgaty, K., Bhatt, R., and Garber, G. (1998) Clinical and microbiological aspects of Trichomonas vaginalis. Clin Microbiol Rev 11: 300-317.
23. Rasoloson, D., Tomková, E., Cammack, R., Kulda, J., and Tachezy, J. (2001) Metronidazole-resistant strains of Trichomonas vaginalis display increased susceptibility to oxygen. Parasitology 123: 45-56.
24. Schwebke, J.R., and Barrientes, F.J. (2006) Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole. Antimicrob Agents Chemother 50: 4209-4210.
25. Sobel, J.D., Nyiresy, P., and Brown, W. (2001) Tinidazole therapy for metronidazole-resistant vaginal trichomonosis. Clin Infect Dis 33: 1341-1346.
26. Tanabe, M. (1979) Trichomonas vaginalis: NADH oxidase activity. Exp Parasitol 48: 143-145.
27. Upcroft, J.A., Dunn, L., Wal, T., Tabrizi, S., Delgadillo-Correa, M.G., Johnson, P.J., etal. (2009) Metronidazole resistance in Trichomonas vaginalis from highland women in Papua New Guinea. Sex Health 6: 334-338.
28. Upcroft, P., and Upcroft, J.A. (2001) Drug targets and mechanisms of resistance in the anaerobic protozoa. Clin Microbiol Rev 14: 150-164.
29. Wassmann, C., Hellberg, A., Tannich, E., and Bruchhaus, I. (1999) Metronidazole resistance in the protozoan parasite Entamoeba histolytica is associated with increased expression of iron-containing superoxide dismutase and peroxiredoxin and decreased expression of ferredoxin 1 and flavin reductase. J Biol Chem 274: 26051-26056.
30. Williams, C.F., Lloyd, D., Kolarich, D., Alagesan, K., Duchêne, M., Cable, J., etal. (2012) Disrupted intracellular redox balance of the diplomonad fish parasite Spironucleus vortens by 5-nitroimidazoles and garlic-derived compounds. Vet Parasitol 190: 62-73.
31. Yarlett, N., Gorell, T.E., Marczak, R., and Müller, M. (1985) Reduction of nitroimidazole derivatives by hydrogenosomal extracts of Trichomonas vaginalis. Mol Biochem Parasitol 14: 29-40.
32. Yarlett, N., Yarlett, N.C., and Lloyd, D. (1986a) Metronidazole-resistant clinical isolates of Trichomonas vaginalis have lowered oxygen affinities. Mol Biochem Parasitol 19: 111-116.
33. Yarlett, N., Yarlett, N.C., and Lloyd, D. (1986b) Ferredoxin-dependent reduction of nitroimidazole derivatives in drug-resistant and susceptible strains of Trichomonas vaginalis. Biochem Pharmacol 35: 1703-1708.